Cardlytics, Inc.
CDLX NasdaqΒ· Services-Computer Programming, Data Processing, Etc.
Last close Β· Oct 23, 2026
$1.80
KIRA Β· Stoqlyβs AI analyst, in plain words
- Cardlytics, Inc. had $233M of revenue in fiscal 2025, down 16.2% on the year before. Over five years, revenue changed +4.5% a year on average.
- Its operating margin was β43.6%, up 26.6Β pts: of every 100 in sales, about β44 is left after running the business.
- Cardlytics, Inc. lost $103M in fiscal 2025.
- Free cash flow was $8.8M in fiscal 2025, 3.8% of revenue.
- Cardlytics, Inc. owes $160M more than it holds in cash.
Market cap
$10.4M
P/E
β
Revenue
$233M
Net income
β$103M
Free cash flow
$8.8M
Operating margin
β43.6%
Cardlytics, Inc. in 30 seconds Β· fiscal 2025
Are sales growing?
β16.2%
No. Sales fell 16.2% last year.
Does it make a profit?
β44.4%
No. It lost money last year.
Does profit turn into cash?
3.8%
Partly. 3.8% of sales ends up as free cash.
How healthy are the accounts?
5 / 8
Mixed. It passes 5 of 8 health tests.
How is the share priced?
β
No P/E: it made no profit over the last four quarters.
What Cardlytics, Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 4, 2026
- Legal name
- Cardlytics, Inc.
- CIK
- 0001666071
Cardlytics, Inc. Β· CDLX
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $267M | $299M | $309M | $278M | $233M |
| Revenue growth | 42.9% | 11.8% | 3.6% | β10.0% | β16.2% |
| Net interest income | β$12.6M | β$2.6M | β$2.3M | β | β |
| Operating margin | β45.9% | β153.3% | β43.9% | β70.2% | β43.6% |
| Net income | β$129M | β$465M | β$135M | β$189M | β$103M |
| Net margin | β48.1% | β155.8% | β43.6% | β68.0% | β44.4% |
| Diluted EPS | β$3.99 | β$13.92 | β$3.69 | β$3.91 | β$1.95 |
| Cash | |||||
| Cash from operations | β$38.5M | β$53.9M | β$0.2M | β$8.8M | $9.3M |
| Capital expenditure | $3.1M | $1.2M | $0.7M | $1.6M | $0.5M |
| Free cash flow | β$41.6M | β$55.1M | β$0.9M | β$10.4M | $8.8M |
| FCF margin | β15.6% | β18.4% | β0.3% | β3.7% | 3.8% |
| Share buybacks | $0.0M | $40.0M | $0.0M | $0.0M | β |
| Share count change | 18.3% | 3.8% | 9.2% | 32.5% | 9.8% |
| Debt and strength | |||||
| Cash and short-term investments | $233M | $122M | $91.8M | $65.6M | $48.7M |
| Debt incl. finance leases | $184M | $226M | $258M | $259M | $209M |
| Shareholders' equity | $691M | $212M | $135M | $70.0M | β$6.5M |
| Current ratio | 1.1x | 1.0x | 1.3x | 1.2x | 1.8x |
| Interest coverage | β9.7x | β114.4x | β21.9x | β22.0x | β |
| Returns and quality | |||||
| Return on capital | β15.1% | β114.5% | β35.7% | β58.5% | β52.3% |
| Return on equity | β30.3% | β103.1% | β77.8% | β184.9% | β326.0% |
| Piotroski F-score | 3 | 2 | 4 | 2 | 5 |
| Altman Z'' | β0.6 | β8.6 | β7.0 | β13.4 | β17.1 |
Insiders bought, 12 months
$0.1M
1 insider
Insiders sold, 12 months
$0.5M
3 insiders
Of sales under plans
0%
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cardlytics, Inc. Β· CDLX
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $1.80 a share, the company is worth $10.4M.
Source: SEC EDGAR XBRL filings (CIK 0001666071). Data updated October 24, 2026. For information only β not investment advice. Check the original filings before relying on any figure.
